[Aldosterone antagonists in coronary insufficiency].
D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002191:Canrenoic Acid / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects; D009203:Myocardial Infarction / Q000188:drug therapy; D011245:Pregnadienes / Q000627:therapeutic use*; D013148:Spironolactone / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D013268:Stimulation, Chemical
D011245:Pregnadienes; D013148:Spironolactone; D002191:Canrenoic Acid
Aldosteronantagonisten bei Herzinsuffizienz.